Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart Immunotherapy

Variable intralesional immunotherapies have recently been proposed as a means of achieving a successful eradication of recurrent and recalcitrant human papillomavirus (HPV)-induced cutaneous and anogenital warts. The bivalent HPV vaccine is one of the newly proposed immunotherapeutic agents. We inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammad, Noha M., Marei, Ayman, El-Didamony, Gamal, Mortada, Zeinb, Elradi, Mona, Afifi, Amira Hamed Mohamed, Kadry, Heba M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621280/
https://www.ncbi.nlm.nih.gov/pubmed/34835211
http://dx.doi.org/10.3390/vaccines9111280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621280/
https://www.ncbi.nlm.nih.gov/pubmed/34835211
http://dx.doi.org/10.3390/vaccines9111280

Ejemplares similares